Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKGP.L Regulatory News (KGP)

  • There is currently no data for KGP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

15 Nov 2010 07:00

RNS Number : 1383W
Kingspan Group PLC
15 November 2010
 

Kingspan Group Plc

Interim Management Statement

 

15 November 2010

 

Kingspan Group Plc, the leading international provider of low energy building solutions, today issues the following Interim Management Statement for the period from 1 July to 30 September 2010.

 

Group turnover in the 9 months to 30 September was €865mn, up 6% year on year, with third quarter sales up 15% on prior year following a pattern of particularly strong order intake in the second quarter. The performance of the Group's businesses in the UK was solid given the challenging circumstances, and trading in Mainland Europe continued to build upon the improvements earlier in the year. While the North American construction environment remained subdued, Kingspan's Insulated Panel activity continued to grow its position, although office construction predictably weakened further. Ireland remains depressed, and in Australia our businesses have grown significantly throughout the year.

 

By product segment in the third quarter, Insulated Panels performed particularly well in most regions, up 20% year on year. Combined sales in the UK, Ireland and Western Europe grew 16% in quarter three, whilst the medium term project pipeline remained broadly flat through the period, where it had been gradually trending upward over the preceding year. Order intake has however reduced noticeably from the run rate in the second quarter, but was up 3% on prior year in the period. Central & Eastern Europe sales rose 30% in the quarter, and order intake remained encouraging, up 11%. Similarly in North America sales grew by 21%, and intake was up 10% in the period. In recent months, resistance has been experienced in passing through the sizeable steel and chemical cost increases from mid-year, resulting in pressure on margins. This pressure is likely to prevail for the foreseeable future given the expected macro weakness through the turn of the year, which can also be expected to impact on volumes.

 

Insulation Boards performed well in the period, with sales growing by 21% year on year, and up 10% excluding the recent acquisition in Australia. Activity was particularly robust in the UK, and growth was also achieved in the key future markets of Mainland Europe. Despite government incentive programmes being discontinued in Australia, the business in this region grew in the period as high performance insulation gradually builds its presence.

 

Environmental & Renewables sales were up 1% in the period, owing in the main to a subdued performance of solar hot water in Germany.

 

Access Floors sales were down 4% in the period. Whilst margins held up relatively well, volumes slipped further, particularly in North America, and are not expected to bottom out until 2011.

 

As announced on 11 November, the Group has agreed to acquire the European insulation activities of CRH for a consideration of approximately €120mn, which is subject to certain statutory approvals, and expected to complete early in 2011. This transaction bolsters Kingspan's position as the number one provider of non-fibrous insulation throughout Europe, and establishes a much wider platform from which to continue growing market penetration into the future. The acquisition is expected to be earnings neutral in 2011, and earnings enhancing thereafter. The deal will be comfortably funded from the Group's current facilities, still leaving Kingspan conservatively geared.

 

Net debt at the end of October 2010 was approximately €140mn, up marginally from the figure of €135.1 reported at 30 June last. This figure is expected to reduce by up to €10mn by year end. Capital expenditure, mainly of a maintenance nature, will be in the region of €20mn for the year as a whole.

 

Looking ahead, the more positive sentiment evident around mid-year has eased back recently as the many individual national austerity programmes become factored into more tame macro forecasts for the year ahead. That broad cautionary sense has also crept into expectations for the construction environment in many of the Group's markets.

 

Kingspan has made clear progress in the growth of its products' positions in many markets, although this underlying dynamic has been somewhat overshadowed by global weakness in recent years. This traction leaves the Board confident that those foundations will deliver significant growth in the future. More near-term however, the year to date performance coupled with the current order book is likely to deliver a 2010 full year operating profit in the range of €62mn to €65mn, compared to €62.7mn in prior year.

 

 

For further information contact:

 

Gene Murtagh, Chief Executive Officer Tel: +353 (0) 42 9698000

 

Dermot Mulvihill, Chief Financial Officer Tel: +353 (0) 42 9698000

 

Ed Micheau, Murray Consultants Tel: +353 (0) 1 4980300

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBRBDBXDBBGGD
Date   Source Headline
18th Aug 20237:05 amRNSDelisting from the London Stock Exchange
18th Aug 20237:00 amRNSHalf-year Report
20th Jul 202311:37 amRNSResult of EGM
20th Jul 20239:56 amRNSHolding(s) in Company
18th Jul 20237:00 amRNSAcquisition
11th Jul 20237:00 amRNSTrading Update
3rd Jul 20232:40 pmRNSBlock listing Interim Review
3rd Jul 20232:34 pmRNSTotal Voting Rights
30th Jun 20234:54 pmRNSHolding(s) in Company
26th Jun 20232:00 pmRNSCircular and Notice of EGM
23rd Jun 20234:08 pmRNSHolding(s) in Company
14th Jun 20234:56 pmRNSHolding(s) in Company
14th Jun 20234:54 pmRNSHolding(s) in Company
1st Jun 20235:25 pmRNSTotal Voting Rights
2nd May 20235:09 pmRNSTotal Voting Rights
28th Apr 20234:07 pmRNSDirectorate Change
28th Apr 20234:00 pmRNSResult of AGM
28th Apr 20237:00 amRNSTrading Statement
3rd Apr 20234:40 pmRNSTotal Voting Rights
30th Mar 20239:00 amRNSDirector/PDMR Shareholding
21st Mar 20235:24 pmRNSDirector/PDMR Shareholding
20th Mar 20235:29 pmRNSHolding(s) in Company
20th Mar 20235:28 pmRNSHolding(s) in Company
16th Mar 20234:29 pmRNSHolding(s) in Company
16th Mar 20232:05 pmRNSNotice of AGM
1st Mar 20234:28 pmRNSTotal Voting Rights
1st Mar 20233:33 pmRNSHolding(s) in Company
1st Mar 202312:39 pmRNSDirector/PDMR Shareholding
28th Feb 20231:11 pmRNSDirector/PDMR Shareholding
24th Feb 20231:09 pmRNSHolding(s) in Company
23rd Feb 20234:57 pmRNSAnnual Financial Report
23rd Feb 20239:00 amRNSDirector/PDMR Shareholding
21st Feb 20235:34 pmRNSDirector/PDMR Shareholding
21st Feb 20235:28 pmRNSDirector/PDMR Shareholding
17th Feb 20237:30 amRNSDirectorate Change
17th Feb 20237:00 amRNSFinal Results
13th Feb 20236:02 pmRNSHolding(s) in Company
10th Feb 20233:00 pmRNSHolding(s) in Company
8th Feb 20234:35 pmRNSPrice Monitoring Extension
3rd Feb 20232:12 pmRNSHolding(s) in Company
2nd Feb 20234:27 pmRNSHolding(s) in Company
30th Jan 20232:48 pmRNSHolding(s) in Company
26th Jan 20234:40 pmRNSSecond Price Monitoring Extn
26th Jan 20234:35 pmRNSPrice Monitoring Extension
25th Jan 20234:05 pmRNSHolding(s) in Company
19th Jan 20237:00 amRNSHolding(s) in Company
17th Jan 20234:40 pmRNSHolding(s) in Company
3rd Jan 20239:05 amRNSBlock listing Interim Review
3rd Jan 20239:00 amRNSTotal Voting Rights
21st Dec 20224:14 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.